Trillium Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $380K | Hold |
15,799
| – | – | 0.01% | 203 |
|
|
2026
Q1 | $444K | Hold |
15,799
| – | – | 0.01% | 194 |
|
|
2025
Q4 | $393K | Hold |
15,799
| – | – | 0.01% | 201 |
|
|
2025
Q3 | $403K | Sell |
15,799
-221
| -1% | -$5.46K | 0.01% | 198 |
|
|
2025
Q2 | $388K | Sell |
16,020
-356
| -2% | -$8.3K | 0.01% | 199 |
|
|
2025
Q1 | $415K | Hold |
16,376
| – | – | 0.01% | 193 |
|
|
2024
Q4 | $434K | Sell |
16,376
-400
| -2% | -$10.8K | 0.01% | 195 |
|
|
2024
Q3 | $485K | Hold |
16,776
| – | – | 0.01% | 196 |
|
|
2024
Q2 | $469K | Hold |
16,776
| – | – | 0.01% | 200 |
|
|
2024
Q1 | $466K | Hold |
16,776
| – | – | 0.01% | 203 |
|
|
2023
Q4 | $483K | Hold |
16,776
| – | – | 0.01% | 195 |
|
|
2023
Q3 | $556K | Sell |
16,776
-893
| -5% | -$31.6K | 0.02% | 188 |
|
|
2023
Q2 | $648K | Sell |
17,669
-2,190
| -11% | -$85.2K | 0.02% | 179 |
|
|
2023
Q1 | $772K | Sell |
19,859
-2,147
| -10% | -$92.7K | 0.02% | 172 |
|
|
2022
Q4 | $1.13M | Sell |
22,006
-1,103
| -5% | -$52.9K | 0.03% | 169 |
|
|
2022
Q3 | $1.01M | Buy |
23,109
+3,500
| +18% | +$170K | 0.03% | 167 |
|
|
2022
Q2 | $1.03M | Buy |
19,609
+250
| +1% | +$12.7K | 0.03% | 167 |
|
|
2022
Q1 | $1M | Sell |
19,359
-126
| -0.6% | -$6.54K | 0.03% | 181 |
|
|
2021
Q4 | $1.15M | Hold |
19,485
| – | – | 0.03% | 183 |
|
|
2021
Q3 | $838K | Buy |
19,485
+307
| +2% | +$13.6K | 0.02% | 183 |
|
|
2021
Q2 | $751K | Sell |
19,178
-4,963
| -21% | -$193K | 0.02% | 187 |
|
|
2021
Q1 | $875K | Sell |
24,141
-1,048
| -4% | -$37.2K | 0.03% | 179 |
|
|
2020
Q4 | $927K | Sell |
25,189
-584
| -2% | -$21.4K | 0.03% | 178 |
|
|
2020
Q3 | $897K | Sell |
25,773
-5,640
| -18% | -$198K | 0.04% | 166 |
|
|
2020
Q2 | $975K | Sell |
31,413
-2,179
| -6% | -$74K | 0.04% | 175 |
|
|
2020
Q1 | $1.04M | Sell |
33,592
-3,407
| -9% | -$116K | 0.05% | 170 |
|
|
2019
Q4 | $1.38M | Sell |
36,999
-9,755
| -21% | -$347K | 0.06% | 180 |
|
|
2019
Q3 | $1.59M | Buy |
46,754
+13,859
| +42% | +$504K | 0.07% | 174 |
|
|
2019
Q2 | $1.35M | Sell |
32,895
-323
| -1% | -$12.8K | 0.07% | 174 |
|
|
2019
Q1 | $1.34M | Buy |
33,218
+20,274
| +157% | +$812K | 0.07% | 176 |
|
|
2018
Q4 | $536K | Sell |
12,944
-1,884
| -13% | -$78.2K | 0.03% | 193 |
|
|
2018
Q3 | $620K | Buy |
14,828
+1,339
| +10% | +$51.5K | 0.03% | 195 |
|
|
2018
Q2 | $464K | Sell |
13,489
-183
| -1% | -$6.25K | 0.02% | 200 |
|
|
2018
Q1 | $460K | Buy |
13,672
+1,622
| +13% | +$55.8K | 0.03% | 201 |
|
|
2017
Q4 | $414K | Sell |
12,050
-298
| -2% | -$10.2K | 0.02% | 197 |
|
|
2017
Q3 | $418K | Buy |
12,348
+1,371
| +12% | +$44.1K | 0.02% | 191 |
|
|
2017
Q2 | $350K | Hold |
10,977
| – | – | 0.02% | 196 |
|
|
2017
Q1 | $356K | Sell |
10,977
-3,357
| -23% | -$106K | 0.02% | 188 |
|
|
2016
Q4 | $442K | Sell |
14,334
-564
| -4% | -$17.2K | 0.03% | 188 |
|
|
2016
Q3 | $479K | Buy |
14,898
+192
| +1% | +$6.42K | 0.03% | 185 |
|
|
2016
Q2 | $491K | Sell |
14,706
-768
| -5% | -$24.5K | 0.03% | 189 |
|
|
2016
Q1 | $435K | Sell |
15,474
-1,699
| -10% | -$48.5K | 0.03% | 181 |
|
|
2015
Q4 | $526K | Sell |
17,173
-2,002
| -10% | -$63K | 0.04% | 181 |
|
|
2015
Q3 | $571K | Sell |
19,175
-448
| -2% | -$14.4K | 0.04% | 176 |
|
|
2015
Q2 | $624K | Sell |
19,623
-211
| -1% | -$6.88K | 0.04% | 172 |
|
|
2015
Q1 | $655K | Buy |
19,834
+1,489
| +8% | +$47.3K | 0.04% | 170 |
|
|
2014
Q4 | $542K | Buy |
18,345
+972
| +6% | +$27.9K | 0.04% | 175 |
|
|
2014
Q3 | $487K | Buy |
17,373
+4,111
| +31% | +$115K | 0.04% | 159 |
|
|
2014
Q2 | $373K | Sell |
13,262
-267
| -2% | -$7.61K | 0.03% | 163 |
|
|
2014
Q1 | $412K | Sell |
13,529
-2,530
| -16% | -$75.4K | 0.04% | 159 |
|
|
2013
Q4 | $467K | Buy |
16,059
+665
| +4% | +$19.4K | 0.05% | 156 |
|
|
2013
Q3 | $420K | Buy |
15,394
+6,134
| +66% | +$167K | 0.05% | 159 |
|
|
2013
Q2 | $246K | Buy |
+9,260
| New | +$256K | 0.03% | 163 |
|
Other funds holding PFE
Trillium Asset Management's PFE Position: Q2 2026 in Review
Trillium Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 15,799 shares worth $380K. The position accounts for 0.01% of the portfolio, ranked #203.
Trillium Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.59M in Q3 2019. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Trillium Asset Management held 15,799 shares of Pfizer worth $380K as of Q2 2026.
- Trillium Asset Management left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.01% of Trillium Asset Management's portfolio in Q2 2026, its #203 holding.
- Trillium Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Trillium Asset Management's Pfizer position peaked at $1.59M in Q3 2019.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Trillium Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.